Tag: AI

mci-onehealth-announces-investment-in-ariel-precision-medicine

MCI Onehealth Announces Investment in Ariel Precision Medicine

onit-releases-a-new,-modern-look-for-its-workflow-automation-and-ai-platforms-and-products

Onit Releases a New, Modern Look for Its Workflow Automation and AI Platforms and Products

global-flavors-and-fragrances-market-is-expected-to-reach-$35.91-billion-by-2027:-says-amr

Global Flavors and Fragrances Market Is Expected to Reach $35.91 Billion by 2027: Says AMR

darkpulse,-inc-solidifies-strategic-partnership-with-drone-based-ai.-company-remote-intelligence

DarkPulse, Inc. Solidifies Strategic Partnership with Drone Based A.I. Company Remote Intelligence

mursion-appoints-global-assessment-professional-nikki-eatchel-as-chief-learning-officer

Mursion Appoints Global Assessment Professional Nikki Eatchel as Chief Learning Officer

wellteq-launches-beta-production-of-internet-of-medical-things-(iomt)-healthhub-with-api-as-a-service

Wellteq Launches Beta Production of Internet of Medical Things (IoMT) HealthHub with API as a Service

corvel-names-joseph-rupp-as-area-vice-president

CorVel Names Joseph Rupp as Area Vice President

bioxcel-therapeutics-launches-“boiling-point”-educational-campaign-to-shed-light-on-the-importance-of-prompt-and-cooperative-de-escalation-in-the-acute-treatment-of-agitation-associated-with-schizophrenia-and-bipolar-disorders

BioXcel Therapeutics Launches “Boiling Point” Educational Campaign to Shed Light on the Importance of Prompt and Cooperative De-escalation in the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders

antidepressants-market-size-2021-|-is-projected-to-reach-usd-1829-billion-by-2027,-exhibiting-a-cagr-of-2.9%-during-2020-2027

Antidepressants Market Size 2021 | Is Projected to Reach USD 18.29 Billion by 2027, Exhibiting a CAGR of 2.9% during 2020-2027

ventilator-market-size-2021-|-to-reach-usd-913-billion-by-2027-and-exhibit-5.0%-cagr

Ventilator Market Size 2021 | To Reach USD 9.13 Billion by 2027 and Exhibit 5.0% CAGR